Trades on 2 secondary markets

Enlaza Therapeutics

Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla, California developing first-in-class covalent protein biologics for cancer and other serious diseases. Its proprietary War-Lock technology uses engineered unnatural amino acids to enable protein drugs — including antibody

minimal 13.9 / 100 0 APIs View provider profile →
CompanyBiotechnologyPharmaceuticalsTherapeuticsOncologyBiologics

Enlaza Therapeutics is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.